These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 32892549

  • 1. The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism.
    Demirci T, Cengiz H, Varım C, Çetin S.
    Turk J Med Sci; 2020 Dec 17; 50(8):1976-1982. PubMed ID: 32892549
    [Abstract] [Full Text] [Related]

  • 2. May AMH levels distinguish LOCAH from PCOS among hirsute women?
    Oncul M, Sahmay S, Tuten A, Acikgoz AS, Gurleyen HC.
    Eur J Obstet Gynecol Reprod Biol; 2014 Jul 17; 178():183-7. PubMed ID: 24792539
    [Abstract] [Full Text] [Related]

  • 3. Serum AMH levels in the differential diagnosis of hyperandrogenemic conditions.
    Tuten A, Sahmay S, Oncul M, Acikgoz AS, Imamoglu M, Gurleyen HC, Senturk ML.
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun 17; 177():121-5. PubMed ID: 24768424
    [Abstract] [Full Text] [Related]

  • 4. The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia.
    Kamel N, Tonyukuk V, Emral R, Corapçioğlu D, Baştemir M, Güllü S.
    Endocr J; 2003 Dec 17; 50(6):815-23. PubMed ID: 14709856
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis of late-onset congenital adrenal hyperplasia in clinical practice: current evaluation.
    Sahmay S, Tuten A, Gurleyen H, Oncul M, Benian A, Tamer Erel C.
    Minerva Endocrinol; 2014 Sep 17; 39(3):215-22. PubMed ID: 25068307
    [Abstract] [Full Text] [Related]

  • 6. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
    Luboshitzky R, Herer P, Shen-Orr Z.
    Exp Clin Endocrinol Diabetes; 2004 Feb 17; 112(2):102-7. PubMed ID: 15031776
    [Abstract] [Full Text] [Related]

  • 7. Is acne a sign of androgen excess disorder or not?
    Uysal G, Sahin Y, Unluhizarci K, Ferahbas A, Uludag SZ, Aygen E, Kelestimur F.
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr 17; 211():21-25. PubMed ID: 28178574
    [Abstract] [Full Text] [Related]

  • 8. The prevalence, molecular analysis and HLA typing of late-onset 21-hydroxylase deficiency in Turkish woman with hirsutism and polycystic ovary.
    Yarman S, Dursun A, Oguz F, Alagol F.
    Endocr J; 2004 Feb 17; 51(1):31-6. PubMed ID: 15004406
    [Abstract] [Full Text] [Related]

  • 9. Hirsutism in Saudi females of reproductive age: a hospital-based study.
    Al-Ruhaily AD, Malabu UH, Sulimani RA.
    Ann Saudi Med; 2008 Feb 17; 28(1):28-32. PubMed ID: 18299651
    [Abstract] [Full Text] [Related]

  • 10. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study.
    Tehrani FR, Rashidi H, Azizi F.
    Reprod Biol Endocrinol; 2011 Nov 01; 9():144. PubMed ID: 22044512
    [Abstract] [Full Text] [Related]

  • 11. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
    Pall M, Azziz R, Beires J, Pignatelli D.
    Fertil Steril; 2010 Jul 01; 94(2):684-9. PubMed ID: 19726039
    [Abstract] [Full Text] [Related]

  • 12. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
    Erel CT, Senturk LM, Oral E, Colgar U, Ertungealp E.
    Gynecol Endocrinol; 1998 Aug 01; 12(4):223-9. PubMed ID: 9798131
    [Abstract] [Full Text] [Related]

  • 13. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul 01; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 14. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS, Thompson DL.
    J Clin Endocrinol Metab; 1990 Apr 01; 70(4):1096-102. PubMed ID: 2156885
    [Abstract] [Full Text] [Related]

  • 15. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S, Rey F, Reymond MJ, Meuwly JY, Gaillard RC, Gomez F.
    Medicine (Baltimore); 2009 Jan 01; 88(1):32-45. PubMed ID: 19352298
    [Abstract] [Full Text] [Related]

  • 16. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
    Pignatelli D.
    Front Horm Res; 2013 Jan 01; 40():158-70. PubMed ID: 24002412
    [Abstract] [Full Text] [Related]

  • 17. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
    Bidzińska B, Tworowska U, Demissie M, Milewicz A.
    Przegl Lek; 2000 Jan 01; 57(7-8):393-6. PubMed ID: 11109312
    [Abstract] [Full Text] [Related]

  • 18. [Differential diagnosis of hirsutism in girls between 15-19 years old].
    Baron JJ, Baron J.
    Ginekol Pol; 1993 May 01; 64(5):267-9. PubMed ID: 8365685
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B, Slopien R, Warenik-Szymankiewicz A.
    Eur J Obstet Gynecol Reprod Biol; 2007 May 01; 132(1):88-92. PubMed ID: 16979812
    [Abstract] [Full Text] [Related]

  • 20. High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms.
    Di Fede G, Mansueto P, Pepe I, Rini GB, Carmina E.
    Fertil Steril; 2010 Jun 01; 94(1):194-7. PubMed ID: 19338993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.